SecBot SecBot
SECBOTREPLAY Home › Report › BLFS

BLFS · Repligen filed supplemental disclosures to the proxy…

BIOLIFE SOLUTIONS INC · 425 filed Sep 30, 2026 at 06:01 ET

At the news

NEUTRALIMPACT 4/10

425 filed Sep 30, 2026 at 06:01 ET

Repligen filed supplemental disclosures to the proxy statement/prospectus for its pending acquisition of BioLife Solutions, responding to two shareholder lawsuits filed in New York state court on September 10, 2026. The lawsuits allege inadequate disclosures regarding financial projections, financial advisor analyses, and director conflicts. The supplemental disclosures clarify that Repligen is negotiating employment offers for certain BioLife executives and that cash severance payments will be made at closing regardless of termination, converting them to single-trigger payments. The special stockholder meeting is scheduled for October 5, 2026.

  • Two shareholder lawsuits filed September 10, 2026 in New York Supreme Court allege proxy statement omissions regarding financial projections, advisor analyses, and director conflicts.
  • Supplemental disclosures clarify that Repligen expects to pay cash severance to named executive officers at closing regardless of a Qualifying Termination (single-trigger).
  • Repligen is negotiating offer letters with Dr. Mathew, Mr. Berard, and Mr. Werner for continued employment post-merger.
  • Special stockholder meeting to vote on the merger is scheduled for October 5, 2026 at 9:00 a.m. Eastern Time.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access